Perseverance Asset Management International I Mab Transaction History

Perseverance Asset Management International

$735 Million
Q2 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$12.54 - $46.93 $459,942 - $1.72 Million	-36,678 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$45.28 - $74.5 $4.35 Million - $7.17 Million	-96,176 Reduced 72.39%	36,678 $1.74 Million
Q3 2021 Nov 15, 2021	SELL	$57.18 - $84.43 $17.9 Million - $26.4 Million	-313,120 Reduced 70.21%	132,854 $9.63 Million
Q2 2021 Aug 16, 2021	BUY	$47.86 - $83.95 $5.26 Million - $9.22 Million	109,867 Added 32.69%	445,974 $37.4 Million
Q1 2021 May 17, 2021	BUY	$44.38 - $63.97 $11 Million - $15.8 Million	247,107 Added 277.65%	336,107 $16.3 Million
Q4 2020 Feb 16, 2021	BUY	$32.94 - $47.15 $2.93 Million - $4.2 Million	89,000 New	89,000 $4.2 Million

Others Institutions Holding IMAB

# of Institutions

Shares Held

15.6M

Call Options Held

Put Options Held

1.9K

Hhlr Advisors, Ltd. Grand Cayman, E9

6.91M
Shares

$7.53 Million
0.3% of portfolio
Decheng Capital Management Iii (Cayman), LLC

4.17M
Shares

$4.54 Million
3.04% of portfolio
Boothbay Fund Management, LLC New York, NY

1.38M
Shares

$1.5 Million
0.07% of portfolio
David A. Siegel Two Sigma Advisers, LP | New York, Ny

577K
Shares

$628,494
0.0% of portfolio
Two Sigma Investments, LP New York, NY

478K
Shares

$521,501
0.0% of portfolio

View Full List

About I-Mab

Ticker IMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,098,800
Market Cap $90.6M
Description
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...

More about IMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perseverance Asset Management International, based on Form 13F filings with the SEC.

News

Stay updated on Perseverance Asset Management International with notifications on news.

Account